TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2011

State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Alabama 192 29.6 5.4 (19.0 – 40.2) 210 29.3 5.2 (19.1 – 39.5)
Arizona 228 23.6 5.3 (13.2 – 34.0) 249 22.2 4.9 (12.6 – 31.8)
California 506 32.9 3.2 (26.6 – 39.2) 535 33.5 3.0 (27.6 – 39.4)
Connecticut 252 36.7 5.5 (25.9 – 47.5) 277 34.3 5.0 (24.5 – 44.1)
District of Columbia 151 42.2 7.2 (28.1 – 56.3) 169 41.2 6.9 (27.7 – 54.7)
Florida 367 31.1 5.1 (21.1 – 41.1) 416 28.8 4.7 (19.6 – 38.0)
Georgia 261 33.5 5.8 (22.1 – 44.9) 270 34.4 5.8 (23.0 – 45.8)
Hawaii 246 36.6 5.7 (25.4 – 47.8) 257 39.0 5.8 (27.6 – 50.4)
Illinois 175 33.0 6.1 (21.0 – 45.0) 186 31.9 5.9 (20.3 – 43.5)
Indiana 330 35.8 4.1 (27.8 – 43.8) 342 35.3 4.0 (27.5 – 43.1)
Iowa 197 29.1 4.6 (20.1 – 38.1) 206 26.9 4.2 (18.7 – 35.1)
Kansas 737 36.5 3.3 (30.0 – 43.0) 761 37.2 3.3 (30.7 – 43.7)
Louisiana 267 23.0 4.8 (13.6 – 32.4) 282 21.0 4.5 (12.2 – 29.8)
Maine 272 46.6 4.9 (37.0 – 56.2) 295 42.4 4.8 (33.0 – 51.8)
Maryland 211 31.9 4.9 (22.3 – 41.5) 224 30.9 4.7 (21.7 – 40.1)
Massachusetts 237 37.7 6.6 (24.8 – 50.6) 249 37.1 6.4 (24.6 – 49.6)
Michigan 498 37.8 4.1 (29.8 – 45.8) 544 35.5 3.9 (27.9 – 43.1)
Mississippi 262 25.7 5.5 (14.9 – 36.5) 278 26.2 5.3 (15.8 – 36.6)
Missouri 218 33.8 5.2 (23.6 – 44.0) 221 33.0 5.3 (22.6 – 43.4)
Montana 340 32.1 4.1 (24.1 – 40.1) 353 29.5 4.0 (21.7 – 37.3)
Nebraska 665 31.8 3.4 (25.1 – 38.5) 713 30.3 3.3 (23.8 – 36.8)
Nevada 134 38.4 8.8 (21.2 – 55.6) 141 36.0 8.5 (19.3 – 52.7)
New Hampshire 222 40.9 5.5 (30.1 – 51.7) 238 36.8 5.1 (26.8 – 46.8)
New Jersey 343 30.8 4.7 (21.6 – 40.0) 367 29.9 4.5 (21.1 – 38.7)
New Mexico 316 30.1 4.2 (21.9 – 38.3) 340 28.8 3.9 (21.2 – 36.4)
New York 135 39.7 6.2 (27.5 – 51.9) 146 39.4 5.8 (28.0 – 50.8)
North Carolina 229 39.8 6.0 (28.0 – 51.6) 241 40.4 5.8 (29.0 – 51.8)
North Dakota 176 41.8 7.5 (27.1 – 56.5) 186 41.5 7.4 (27.0 – 56.0)
Ohio 325 30.9 4.4 (22.3 – 39.5) 336 31.4 4.4 (22.8 – 40.0)
Oklahoma 295 24.1 3.4 (17.4 – 30.8) 312 25.7 3.4 (19.0 – 32.4)
Oregon 183 33.1 5.9 (21.5 – 44.7) 199 30.3 5.2 (20.1 – 40.5)
Pennsylvania 380 36.3 4.1 (28.3 – 44.3) 412 35.4 3.8 (28.0 – 42.8)
Rhode Island 248 33.1 4.6 (24.1 – 42.1) 270 30.4 4.3 (22.0 – 38.8)
Texas 521 36.8 4.2 (28.6 – 45.0) 570 37.5 4.0 (29.7 – 45.3)
Utah 410 26.0 3.5 (19.1 – 32.9) 454 24.6 3.3 (18.1 – 31.1)
Vermont 306 45.4 4.5 (36.6 – 54.2) 315 44.5 4.4 (35.9 – 53.1)
Washington 664 32.5 2.9 (26.8 – 38.2) 666 33.1 2.9 (27.4 – 38.8)
West Virginia 197 39.6 5.7 (28.4 – 50.8) 200 39.9 5.7 (28.7 – 51.1)
Wisconsin 244 47.3 6.5 (34.6 – 60.0) 244 48.9 6.5 (36.2 – 61.6)
Puerto Rico 293 17.6 3.7 (10.3 – 24.9) 323 16.7 3.5 (9.8 – 23.6)
40 state total 12,233 34.0 1.1 (31.8 – 36.2) 12,997 33.5 1.0 (31.5 – 35.5)
Median   33.3       33.3    
Range   17.6-47.3       16.7-48.9    

1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline sample size excludes “DK/Refused”
§ Standard error
Confidence interval